Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Lee's Pharmaceutical licenses RegeneRx candidates in China, Hong Kong and Macau

March 28, 2012

No Comments

Peptide vaccine to enter phase IIa study

March 26, 2012

No Comments

NicOx enters option agreement for acquisition

March 23, 2012

No Comments

Aerpio discloses phase I data on agent for diabetic macular edema

March 21, 2012

No Comments

Santhera reports novel mitochondrial function modulators

March 20, 2012

No Comments

Ampio provides update on Optina trial

March 20, 2012

No Comments

FDA grants orphan drug status to verteporfin therapy

March 19, 2012

No Comments

Alcon and Astellas Pharma report new bradykinin receptor agonists

March 19, 2012

No Comments

Thrombogenics and Alcon enter commercialization agreement for ocriplasmin

March 16, 2012

No Comments

Phase III OMS-302 study meets endpoints

March 14, 2012

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Lee's Pharmaceutical licenses RegeneRx candidates in China, Hong Kong and Macau

Peptide vaccine to enter phase IIa study

NicOx enters option agreement for acquisition

Aerpio discloses phase I data on agent for diabetic macular edema

Santhera reports novel mitochondrial function modulators

Ampio provides update on Optina trial

FDA grants orphan drug status to verteporfin therapy

Alcon and Astellas Pharma report new bradykinin receptor agonists

Thrombogenics and Alcon enter commercialization agreement for ocriplasmin

Phase III OMS-302 study meets endpoints

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Ocular RSS

Ocular
RSS